Re: Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract.
Pollak
M N
MN
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D009153:Mutagens / Q000009:adverse effects*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D012307:Risk Factors
D000970:Antineoplastic Agents; D009153:Mutagens